Here’s what you should know.
1. The new facility will create 70 jobs when complete.
2. Takeda aims to use the plant to expand its footprint in the country, while also manufacturing novel stem cell therapies.
3. The facility is expected to open in 2021.
4. Takeda is already constructing a standalone production facility in Dublin for a portion of its oncology products.
More articles on supply chain:
11 ASC quality statistics for Q3 2017
Surgery Partners to focus on value creation in 2018: 5 quotes from CEO Wayne DeVeydt
49% of anesthesiologists take more than 3 weeks of vacation and 4 other statistics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.